Joseph Rubin

4.0k total citations · 3 hit papers
54 papers, 3.0k citations indexed

About

Joseph Rubin is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Joseph Rubin has authored 54 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 13 papers in Molecular Biology and 12 papers in Surgery. Recurrent topics in Joseph Rubin's work include Colorectal Cancer Treatments and Studies (14 papers), Cancer Treatment and Pharmacology (8 papers) and Gastroesophageal reflux and treatments (7 papers). Joseph Rubin is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Cancer Treatment and Pharmacology (8 papers) and Gastroesophageal reflux and treatments (7 papers). Joseph Rubin collaborates with scholars based in United States, South Africa and Switzerland. Joseph Rubin's co-authors include Edward T. Creagan, Charles G. Moertel, Michael J. O’Connell, Thomas R. Fleming, Matthew M. Ames, Stephen Frytak, Allan J. Schutt, Judith R. OʼFallon, C G Moertel and James B. Gerstner and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Joseph Rubin

53 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

1989 526 citations John A. Laurie, C G Moertel et al. Journal of Clinical Oncology profile →
High-Dose Vitamin C versus Placebo in the Treatment of Patients with Advanced Cancer Who Have Had No Prior Chemotherapy

1985 449 citations Charles G. Moertel, Thomas R. Fleming et al. profile →
Failure of High-Dose Vitamin C (Ascorbic Acid) Therapy to Benefit Patients with Advanced Cancer

1979 416 citations Edward T. Creagan, Charles G. Moertel et al. profile →

Peers

Joseph Rubin

ONCOL

PFM

GENET

Arne Bakka Norway

F. J. Cleton Netherlands

Kenichi Furihata Japan

H S Garewal United States

Toshio Takahashi Japan

K. OGASAWARA Japan

P. L. M. Jansen Netherlands

Harinder S. Garewal United States

G Winde Germany

Véronique Bailly United States

Arne Bakka Norway

Joseph Rubin

1.6k ×1.3

ONCOL

525 ×0.7

354 ×0.5

PFM

580 ×0.9

453 ×0.7

GENET

Citations per year, relative to Joseph Rubin Joseph Rubin (= 1×) peers Arne Bakka

Countries citing papers authored by Joseph Rubin

Since Specialization

Citations

This map shows the geographic impact of Joseph Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Rubin more than expected).

Fields of papers citing papers by Joseph Rubin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Rubin. The network helps show where Joseph Rubin may publish in the future.

Co-authorship network of co-authors of Joseph Rubin

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Rubin. A scholar is included among the top collaborators of Joseph Rubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Rubin. Joseph Rubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rubin, Joseph, et al.. (2024). Augmented Hyper-CVAD (AHCVAD), a Pediatric Inspired Regimen for Adults Younger Than 50 Years of Age with Acute Lymphoblastic Leukemia (ALL), Yields High Rates of MRD Negativity, Favorable 3-Year Overall Survival Regardless of Allogeneic Stem Cell Transplant (ASCT): A Single Center Experience. Blood. 144(Supplement 1). 1448–1448.

Hurwitz, Herbert I., David C. Smith, Henry C. Pitot, et al.. (2015). Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man study. Cancer Chemotherapy and Pharmacology. 75(4). 851–859. 61 indexed citations

Borad, Mitesh J., Henry C. Pitot, Joseph Rubin, et al.. (2012). Pilot Study of Tigatuzumab (CS-1008) in Combination with Folfiri in Patients with Metastatic Colorectal Cancer (CRC). Annals of Oncology. 23. ix222–ix222. 1 indexed citations

Bolton, John S., Michael J. O’Connell, Michelle R. Mahoney, et al.. (2011). Hepatic Arterial Infusion and Systemic Chemotherapy After Multiple Metastasectomy in Patients With Colorectal Carcinoma Metastatic to the Liver: A North Central Cancer Treatment Group (NCCTG) Phase II Study, 92-46-52. Clinical Colorectal Cancer. 11(1). 31–37. 15 indexed citations

Taylor, William E., John H. Donohue, Leonard L. Gunderson, et al.. (2002). The mayo clinic experience with multimodality treatment of locally advanced or recurrent colon cancer. Annals of Surgical Oncology. 9(2). 177–185. 65 indexed citations

Reid, T., E. Galanis, James L. Abbruzzese, et al.. (2001). Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial. Gene Therapy. 8(21). 1618–1626. 185 indexed citations

Singh, Bhugwan, et al.. (1999). Thoracoscopic Splanchnicectomy: Pilot Evaluation of a Simple Alternative for Chronic Pancreatic Pain Control. World Journal of Surgery. 23(7). 688–692. 26 indexed citations

Reid, Joel M., et al.. (1997). Pharmacokinetics of 3-methyl-(triazen-1-yl)imidazole-4-carboximide following administration of temozolomide to patients with advanced cancer.. PubMed. 3(12 Pt 1). 2393–8. 63 indexed citations

Ahlquist, David A., Douglas B. McGill, Samuel Schwartz, et al.. (1990). Patterns of occult bleeding in asymptomatic colorectal cancer. Cancer. 63(9). 1826–1830. 82 indexed citations

10.

Laurie, John A., C G Moertel, Thomas R. Fleming, et al.. (1989). Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.. Journal of Clinical Oncology. 7(10). 1447–1456. 526 indexed citations breakdown →

11.

Brock‐Utne, John G., et al.. (1986). Epidural Ketamine for Control of Postoperative Pain. Anesthesia & Analgesia. 65(9). 990–990. 4 indexed citations

12.

Rubin, Joseph, et al.. (1985). Intra-arterial diazepam. A report of 2 cases.. PubMed. 68(12). 891–2. 7 indexed citations

13.

O'Connell, M J, C G Moertel, Joseph Rubin, et al.. (1984). Clinical trial of sequential N-phosphonacetyl-L-aspartate, thymidine, and 5-fluorouracil in advanced colorectal carcinoma.. Journal of Clinical Oncology. 2(10). 1133–1138. 9 indexed citations

14.

Doyle, John A., Harold O. Perry, Joseph Rubin, & Charles G. Moertel. (1984). Treatment of psoriasis with N-phosphonacetyl-L-aspartate. Journal of the American Academy of Dermatology. 10(1). 21–24. 1 indexed citations

15.

Rubin, Joseph, et al.. (1979). Cardiovascular changes during general anaesthesia: for dental surgery. A prospective study of five different anaesthetic techniques.. PubMed. 56(11). 425–8. 1 indexed citations

16.

Kovach, John S., Charles G. Moertel, Stephen Frytak, et al.. (1979). A phase I study of chlorozotocin (NSC 178248). Cancer. 43(6). 2189–2196. 6 indexed citations

17.

Eagan, Robert T., Edward T. Creagan, James N. Ingle, et al.. (1979). VP-16, Cyclophosphamide, Adriamycin and Cis-platinum (V:CAP-I) in Patients with Metastatic Adenocarcinoma of the Lung. Tumori Journal. 65(1). 105–109. 8 indexed citations

18.

OʼFallon, Judith R., O'Connell Mj, Robert G. Hahn, et al.. (1978). Evaluation of a fixed alternating treatment in patients with advanced breast cancer.. PubMed. 1(3). 219–26. 9 indexed citations

19.

Brock‐Utne, John G., et al.. (1978). The effect of glycopyrrolate (Robinul) on the lower oesophageal sphincter. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 25(2). 144–146. 21 indexed citations

20.

Rubin, Joseph, et al.. (1977). Premedication with flunitrazepam in gastro-intestinal endoscopy.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 52(14). 562–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact